AstraZeneca and Daiichi sign $6.9bn cancer drug deal
admin 29th March 2019 Uncategorised 0The collaboration is aligned with AstraZeneca’s science-led strategy in oncology.
More: AstraZeneca and Daiichi sign .9bn cancer drug deal
Source: News
The collaboration is aligned with AstraZeneca’s science-led strategy in oncology.
More: AstraZeneca and Daiichi sign .9bn cancer drug deal
Source: News
© 1994 - 2026 B.M. Pharmaceuticals